Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 2021; Volume 377,Issue 2

Minireview

  • Open Access
    Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
    Zizhen Si and Xidi Wang
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 207-217; DOI: https://doi.org/10.1124/jpet.120.000324

Behavioral Pharmacology

  • You have access
    Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls
    C. M. Diester, E. J. Santos, M. J. Moerke and S. S. Negus
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 232-241; DOI: https://doi.org/10.1124/jpet.120.000464
  • You have access
    Behavioral Battery for Testing Candidate Analgesics in Mice. II. Effects of Endocannabinoid Catabolic Enzyme Inhibitors and ∆9-Tetrahydrocannabinol
    C. M. Diester, A. H. Lichtman and S. S. Negus
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 242-253; DOI: https://doi.org/10.1124/jpet.121.000497

Cardiovascular

  • Open Access
    An Integrative Approach for Improved Assessment of Cardiovascular Safety Data
    Mikael Wallman, Stefan Scheuerer, Eric Martel, Nicolas Pairet, Mats Jirstrand and Johan Gabrielsson
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 218-231; DOI: https://doi.org/10.1124/jpet.120.000348
  • You have access
    COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels
    Mark Szendrey, Jun Guo, Wentao Li, Tonghua Yang and Shetuan Zhang
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 265-272; DOI: https://doi.org/10.1124/jpet.120.000484

Drug Discovery and Translational Medicine

  • You have access
    Possible Involvement of Muscarinic Receptor Blockade in Mirabegron Therapy for Patients with Overactive Bladder
    Shizuo Yamada, Junko Chimoto, Mizuki Shiho, Takashi Okura, Kana Morikawa, Hirokazu Wakuda and Kazumasa Shinozuka
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 201-206; DOI: https://doi.org/10.1124/jpet.120.000301
  • You have access
    Clostridium butyricum Alleviates Gut Microbiota Alteration–Induced Bone Loss after Bariatric Surgery by Promoting Bone Autophagy
    Xueying Shang, Xiaolei Zhang, Cen Du, Zhuoqi Ma, Shi Jin, Na Ao, Jing Yang and Jian Du
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 254-264; DOI: https://doi.org/10.1124/jpet.120.000410

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response
    Bárbara Betônico Berg, Jaqueline Silva Soares, Isabela Ribeiro Paiva, Barbara Maximino Rezende, Milene Alvarenga Rachid, Stêfany Bruno de Assis Cau, Thiago Roberto Lima Romero, Vanessa Pinho, Mauro Martins Teixeira and Marina Gomes Miranda e Castor
    Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 273-283; DOI: https://doi.org/10.1124/jpet.120.000479
Back to top
Previous

In this issue

Journal of Pharmacology and Experimental Therapeutics: 377 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 377, Issue 2
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Minireview
  • Behavioral Pharmacology
  • Cardiovascular
  • Drug Discovery and Translational Medicine
  • Inflammation, Immunopharmacology, and Asthma
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor
  • Nose-to-Brain Delivery
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics